Cover Image

Influence of sex as an intrinsic biological variable in a primary cell model of HIV latency

Saved in:

Bibliographic Details
Main Authors:	A.B. Macedo (Author), L.J. Martins (Author), A.M. Spivak (Author), M.A. Szaniawski (Author), V. Planelles (Author), A. Bosque (Author)
Format:	Book
Published:	Elsevier, 2017-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diverse interferons restrict HIV-1 Infection in macrophages through activation of SAMHD1
by: M. Szaniawski, et al.
Published: (2017)

CL572, a potent agonist of Toll-like receptor 2/7, as a novel latency-reversing agent
by: A. Macedo, et al.
Published: (2015)

Ingenol derivatives are potent reactivators of latent HIV
by: V. Planelles, et al.
Published: (2015)

Triazol-1-ol analogues as novel therapeutic leads towards reactivating and eradicating latent HIV-1 by manipulating SUMOylation of STAT5
by: A. Bosque, et al.
Published: (2015)

Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019)

Shining the RNA-Seq microscope on models of HIV latency
by: C.H. Woelk, et al.
Published: (2015)

Tyrosine kinase inhibition: the new front in HIV cure efforts
by: V. Planelles, et al.
Published: (2019)

Cleavage and polyadenylation specific factor 6 is required for HIV latency reversal
by: Y. Zheng, et al.
Published: (2019)

PP 2.4 - 00038 Age and biological sex but not sex hormones influence IL-15 biological activity
by: C. Stover, et al.
Published: (2022)

Direct and indirect effects of synthetic dual TLR-2 and TLR-7 agonists (Dual TLR-2/7) on latent HIV
by: A.B. Macedo, et al.
Published: (2017)

CD4+ T cells expressing CD32 from HIV-1-positive patients are not enriched for proviral DNA
by: A.M. Spivak, et al.
Published: (2017)

Utilising genetic barcodes to understand the role of silent integration in HIV latency
by: E. Larragoite, et al.
Published: (2019)

PP 1.22 - 00120 Suppression of CD4+ T-cell-intrinsic immunity by HIV-1 latency-reversing HDACi
by: J. Kazmierski, et al.
Published: (2022)

Role of mitochondrial antiviral signaling protein in reactivation of latent HIV-1 in CD4+ T cells
by: C.L. Novis, et al.
Published: (2017)

In-depth transcription profile comparison of multiple primary cell HIV latency models
by: S. Moron-Lopez, et al.
Published: (2019)

Interactions with pathogenic bacteria induce HIV-1 latency in macrophages through altered transcription factor recruitment to the LTR
by: T. Hanley, et al.
Published: (2019)

Single cell analysis reveals molecular signatures of HIV latency in primary cell models
by: S. Telwatte, et al.
Published: (2019)

HIV latency reversal using designed PKC modulators
by: M.D. Marsden, et al.
Published: (2017)

PP 1.17 - 00103 The Ubiquitin Ligase ITCH and CPSF6 Control HIV Transcription
by: V. Planelles, et al.
Published: (2022)

24 Thalidomide reverses latency of HIV-1 provirus
by: S. Samer, et al.
Published: (2016)

Bioactive Compounds from <i>Euphorbia usambarica</i> Pax. with HIV-1 Latency Reversal Activity
by: Yu-Chi Tsai, et al.
Published: (2021)

Galectin-1 promotes HIV-1 latency reactivation
by: J. Rubione, et al.
Published: (2019)

Targeted screens identify new chromatin regulators of HIV latency
by: A.-M. Turner, et al.
Published: (2017)

23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal
by: T.M. Mota, et al.
Published: (2016)

The steroid receptor coactivators are targets for reactivation of HIV latency
by: B.C. Nikolai, et al.
Published: (2015)

Integration site-independent enhancement of latency reversal by HIV-1 Nef
by: X.T. Kuang, et al.
Published: (2017)

13 HIV-1-specific ADCC following anti-latency therapy and analytical treatment interruption
by: W.S. Lee, et al.
Published: (2017)

Co-culture of T-cells with dendritic cells facilitates HIV latency in proliferating CD4+ T-cells: implications for the establishment and reversal of latency
by: N. Kumar, et al.
Published: (2015)

P1 Contribution of lncRNAs in the establishment of HIV latency in central memory CD4 T Cells
by: Wim Trypsteen, et al.
Published: (2017)

PP 1.10 - 00069 Isotretinoin enhances IL-15 mediated HIV latency reversal and reduces the inducible latent reservoir
by: J. Howard, et al.
Published: (2022)

Combinatorial latency reversal activity of inhibitor of apoptosis antagonists with mechanistically distinct classes of HIV latency reversal agents
by: Shane D. Falcinelli, et al.
Published: (2019)

20 Sirtuin1 inhibitor nicotinamide disrupts HIV-1 latency
by: S. Samer, et al.
Published: (2016)

Gut and blood differ in mechanisms governing HIV transcription/latency
by: S. Telwatte, et al.
Published: (2017)

36 Dose-dependent effects of HDACi on T cell activation and HIV latency reversal
by: X.T. Kuang, et al.
Published: (2016)

Intrinsic and Extrinsic Pharmacokinetic Variability of Small Molecule Targeted Cancer Therapy
by: Eric Reyner, et al.
Published: (2020)

Induction of HIV from latency by a novel molecule
by: N.M. Archin, et al.
Published: (2015)

Evaluation of HIV latency reversal using designed PKC modulators in humanized BLT mice
by: M.D. Marsden, et al.
Published: (2015)

HIV-1 transcriptional latency in resting CD4 T-cell
by: M. Benkirane
Published: (2015)

Developing an in vitro model for HIV-1 latency in Tfh cells using tonsillar tissue
by: B. Luttge, et al.
Published: (2017)

Sustained HIV release by single persisting CD4+ T cells during latency disruption
by: J.M. Hataye, et al.
Published: (2015)